Patients should review current information about platform compliance and regulatory standing
GoodRx today released a new research report that looks at insurance coverage for GIP and GLP-1 agonists like Ozempic, Wegovy, and Zepbound, including how coverage has changed from last year to 2025
Payette, and J
If tirzepatide is used with insulin or sulfonylureas, dose adjustments of these medications may be needed to prevent hypoglycaemia
When GLP-1 is secreted from L-cells through the TGR5 agonist, it stimulates GLP-1R in enterochromaffin cells and induces serotonin or 5-hydroxytryptamine (5-HT) secretion from these cells
With pill fatigue on the rise and consumers preferring alternative formats to supplements, other new options are gaining traction most notably topical supplements, inclusive of patches, creams and sprays that transdermally infuse vitamins and nutrients